People: Oculus Innovative Sciences Inc (OCLS.OQ)

OCLS.OQ on NASDAQ Stock Exchange Capital Market

4.13USD
2:25pm EDT
Price Change (% chg)

$0.19 (+4.82%)
Prev Close
$3.94
Open
$3.83
Day's High
$4.26
Day's Low
$3.79
Volume
57,531
Avg. Vol
31,775
52-wk High
$7.00
52-wk Low
$2.73

Search Stocks

Summary

Name Age Since Current Position

Hojabr Alimi

 51 2013 Chairman of the Board

James Schutz

 49 2013 President, Chief Executive Officer, Director

Robert Miller

 70 2004 Chief Financial Officer

Jerry McLaughlin

 2013 Director

Jay Birnbaum

 67 2007 Independent Director

Richard Conley

 62 2006 Independent Director

Gregory French

 51 2000 Independent Director
» Insider Trading

Biographies

Name Description

Hojabr Alimi

 Mr. Hojabr Alimi is Chairman of the Board of Oculus Innovative Sciences, Inc. He is one of the founders of the Company. He held the position of President and Chief Executive Officer of the Company from 1999-February 2013. He has also served as a director of the Company since 1999, and was appointed Chairman of the Board of Directors in June 2006. Prior to co-founding the Company with his spouse in 1999, Mr. Alimi was a corporate microbiologist for Arterial Vascular Engineering. Mr. Alimi received a B.A. in biology from Sonoma State University.

James Schutz

 Mr. James Schutz is President, Chief Executive Officer, Director of Oculus Innovative Sciences, Inc. Mr. Schutz has most recently held the position of the Chief Operating Officer and General Counsel, and has served in various other capacities as an executive officer of the Company since August 2003. He has also served as a director of the Company since May 2004. From August 2001 to August 2003, Mr. Schutz served as General Counsel at Jomed (formerly EndoSonic Corp.), an international medical device company. From 1999 to July 2001, Mr. Schutz served as in-house counsel at Urban Media Communications Corporation, an Internet/telecom company based in Palo Alto, California. Mr. Schutz received a B.A. in economics from the University of California, San Diego and a J.D. from the University of San Francisco School of Law.

Robert Miller

 Mr. Robert Miller is Chief Financial Officer of Oculus Innovative Sciences, Inc. He was a consultant to the company from March 2003 to May 2004. Mr. Miller has served as a director of Scanis, Inc. since 1998 and served as acting Chief Financial Officer from 1998 to June 2006. He was a Chief Financial Officer consultant to Evit Labs from June 2003 to December 2004, Wildlife International Network from October 2002 to December 2005, Endoscopic Technologies from November 2002 to March 2004, Biolog from January 2000 to December 2002 and Webware from August 2000 to August 2002. Prior to this, Mr. Miller was the Chief Financial Officer for GAF Corporation, Penwest Ltd. and Bugle Boy and Treasurer of Mead Corporation. He received a B.A. in economics from Stanford University and an M.B.A. in finance from Columbia University.

Jerry McLaughlin

 Mr. Jerry G. McLaughlin is appointed as the Director of Oculus Innovative Sciences, Inc. Mr. McLaughlin has served as Interim Chief Executive Officer of Applied BioCode, Inc. since November 2011. He also founded in April 2011 and currently serves as President and Chief Executive Officer of DataStream Medical Imaging Systems, Inc., a start-up to develop diagnostic imaging software applications that work in conjunction with existing digital radiology platforms. He previously served as President of DataFlow Information Systems, from July 2007 to December 2011, and President and Chief Executive Officer of CompuMed, Inc. from May 2002 to June 2007.

Jay Birnbaum

 Dr. Jay E. Birnbaum is Independent Director of Oculus Innovative Sciences, Inc. Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies in his area. He previously served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation, where he had responsibility for strategic planning and development of the company’s dermatology portfolio. Dr. Birnbaum is also a co-founder and former Chief Medical Officer of Kythera Biopharmaceuticals, and has served on the board of directors of Excaliard Pharmaceuticals (a company recently acquired by Pfizer) and on the scientific advisory boards of several companies. Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.

Richard Conley

 Mr. Richard Conley is Independent Director of Oculus Innovative Sciences, Inc. Mr. Conley was Chief Operating Officer at Kautz Vineyards, a wine production and marketing and hospitality company, from December 2008 to July 2011. From 2001 to September 2009, he served as Executive Vice President and Chief Operating Officer at Don Sebastiani & Sons International Wine Negociants, a branded wine marketing company. From 1994 to March 2001, he served as Senior Vice President and Chief Operating Officer at Sebastiani Vineyards, a California wine producer, where he was originally hired as Chief Financial Officer in 1994. Mr. Conley received a B.S. in finance and accounting from Western Carolina University and an M.B.A. from St. Mary’s University

Gregory French

 Mr. Gregory M. French is Independent Director of Oculus Innovative Sciences, Inc. Mr. French co-owns G&C Enterprises LLC, a real estate and investment company, which he founded in 1999. He held various engineering and senior management positions at several medical device companies, including Advanced Cardiovascular Systems, Peripheral Systems Group and Arterial Vascular Engineering. Mr. French received a B.S.I.E. from the California Polytechnic State University, San Luis Obispo.

Basic Compensation

Name Fiscal Year Total

Hojabr Alimi

 845,969

James Schutz

 540,057

Robert Miller

 515,021

Jerry McLaughlin

 --

Jay Birnbaum

 --

Richard Conley

 --

Gregory French

 --
As Of 30 Mar 2012

Options Compensation

Name Options Value

Hojabr Alimi

 442,070 3,286,800

James Schutz

 150,000 718,750

Robert Miller

 140,064 369,070

Jerry McLaughlin

 0 0

Jay Birnbaum

 0 0

Richard Conley

 0 0

Gregory French

 0 0

Insider Trading

Name Shares Traded Price

ALIMI HOJABR

 2,500 $0.64

ALIMI HOJABR

 3,000 $0.64

ALIMI HOJABR

 100 $0.65

ALIMI HOJABR

 1,000 $0.65

ALIMI HOJABR

 2,200 $0.65

ALIMI HOJABR

 2,000 $0.65

ALIMI HOJABR

 3,000 $0.63

ALIMI HOJABR

 4,000 $0.64

ALIMI HOJABR

 1,000 $0.63

ALIMI HOJABR

 1,000 $0.63

SCHUTZ JAMES J

 100 $0.80

SCHUTZ JAMES J

 1,000 $0.78

SCHUTZ JAMES J

 11,400 $0.80

SCHUTZ JAMES J

 500 $0.80
» Full list on Insider Trading
Search Stocks